Skip to Main content Skip to Navigation
New interface
Journal articles

Wearable cardioverter defibrillator: Bridge or alternative to implantation?

Abstract : The implantable cardioverter-defibrillator (ICD) is effective to prevent sudden cardiac death (SCD) in selected patients with heart disease known to be at high risk for ventricular arrhythmia. Nevertheless, this invasive and definitive therapy is not indicated in patients with potentially transient or reversible causes of sudden death, or in patients with temporary contra-indication for ICD placement. The wearable cardioverter defibrillator (WCD) is increasingly used for SCD prevention both in patients awaiting ICD implantation or with an estimated high risk of ventricular arrhythmia though to be transient. We conducted a review of current clinical uses and benefits of the WCD, and described its technical aspects, limitations and perspectives.
Complete list of metadata

Cited literature [47 references]  Display  Hide  Download
Contributor : Françoise DIGNAT-GEORGE Connect in order to contact the contributor
Submitted on : Wednesday, April 25, 2018 - 5:43:31 PM
Last modification on : Friday, September 23, 2022 - 10:44:04 AM
Long-term archiving on: : Tuesday, September 25, 2018 - 11:32:51 AM


Publisher files allowed on an open archive




Jeremie Barraud, Jennifer Cautela, Morgane Orabona, Johan Pinto, Olivier Missenard, et al.. Wearable cardioverter defibrillator: Bridge or alternative to implantation?. World Journal of Cardiology, 2017, 9 (6), pp.531-538. ⟨10.4330/wjc.v9.i6.531⟩. ⟨hal-01778545⟩



Record views


Files downloads